Researchers developed a machine-learning model that uses only sleep-wake patterns to predict mood episodes in patients with mood disorders, achieving high accuracy. This approach simplifies real-world mental health monitoring using data from wearables or smartphones.
Aclaris loses 85% of share value after another PhII setback in inflammatory condition
Aclaris Therapeutics’ lead drug has failed another mid-stage test, marking the biotech’s second major setback this year and the autoimmune treatment’s final shot in the
November 14, 2023